Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach

Hyuk Nam Kwon, Mina Kim, He Wen, Sunmi Kang, Hye Ji Yang, Myung Joo Choi, Hee Seung Lee, DalWoong Choi, In Suh Park, Young Ju Suh, Soon Sun Hong, Sunghyouk Park

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Cisplatin has been one of the most widely used anticancer agents, but its nephrotoxicity remains a dose-limiting complication. Here, we evaluated the idiopathic nature and the predose prediction of cisplatin-induced nephrotoxicity using a nuclear magnetic resonance (NMR)-based pharmacometabonomic approach. Cisplatin produced serious toxic responses in some animals (toxic group), but had little effect in others (nontoxic group), as judged by hematological and histological results. The individual metabolic profiles, assessed by urine NMR spectra, showed large differences between the post-administration profiles of the two groups, indicating the relevance of the NMR approach. Importantly, multivariate analysis of the NMR data showed that the toxic and nontoxic groups can be differentiated based on the pretreatment metabolite profiles. Leave-one-out analysis, performed to evaluate the practical performance of our approach, gave a 66% accuracy rate in predicting toxic responses based on the pretreatment metabolite profiles. Hence, we provide a working model that can explain the idiopathic toxicity mechanism based on marker metabolites found by NMR analysis consistent with tissue NADH measurements. Thus, a pharmacometabonomic approach using pretreatment metabolite profiles may help expedite personalized chemotherapy of anticancer drugs.

Original languageEnglish
Pages (from-to)529-537
Number of pages9
JournalKidney International
Volume79
Issue number5
DOIs
Publication statusPublished - 2011 Mar 1

Fingerprint

Cisplatin
Poisons
Magnetic Resonance Spectroscopy
Metabolome
Antineoplastic Agents
NAD
Multivariate Analysis
Urine
Drug Therapy
Pharmaceutical Preparations

Keywords

  • anticancer
  • cisplatin
  • pharmacometabonomics
  • prediction
  • toxicity

ASJC Scopus subject areas

  • Nephrology

Cite this

Kwon, H. N., Kim, M., Wen, H., Kang, S., Yang, H. J., Choi, M. J., ... Park, S. (2011). Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. Kidney International, 79(5), 529-537. https://doi.org/10.1038/ki.2010.440

Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. / Kwon, Hyuk Nam; Kim, Mina; Wen, He; Kang, Sunmi; Yang, Hye Ji; Choi, Myung Joo; Lee, Hee Seung; Choi, DalWoong; Park, In Suh; Suh, Young Ju; Hong, Soon Sun; Park, Sunghyouk.

In: Kidney International, Vol. 79, No. 5, 01.03.2011, p. 529-537.

Research output: Contribution to journalArticle

Kwon, HN, Kim, M, Wen, H, Kang, S, Yang, HJ, Choi, MJ, Lee, HS, Choi, D, Park, IS, Suh, YJ, Hong, SS & Park, S 2011, 'Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach', Kidney International, vol. 79, no. 5, pp. 529-537. https://doi.org/10.1038/ki.2010.440
Kwon, Hyuk Nam ; Kim, Mina ; Wen, He ; Kang, Sunmi ; Yang, Hye Ji ; Choi, Myung Joo ; Lee, Hee Seung ; Choi, DalWoong ; Park, In Suh ; Suh, Young Ju ; Hong, Soon Sun ; Park, Sunghyouk. / Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. In: Kidney International. 2011 ; Vol. 79, No. 5. pp. 529-537.
@article{d120856d21cc4505ad6de3d33df494c6,
title = "Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach",
abstract = "Cisplatin has been one of the most widely used anticancer agents, but its nephrotoxicity remains a dose-limiting complication. Here, we evaluated the idiopathic nature and the predose prediction of cisplatin-induced nephrotoxicity using a nuclear magnetic resonance (NMR)-based pharmacometabonomic approach. Cisplatin produced serious toxic responses in some animals (toxic group), but had little effect in others (nontoxic group), as judged by hematological and histological results. The individual metabolic profiles, assessed by urine NMR spectra, showed large differences between the post-administration profiles of the two groups, indicating the relevance of the NMR approach. Importantly, multivariate analysis of the NMR data showed that the toxic and nontoxic groups can be differentiated based on the pretreatment metabolite profiles. Leave-one-out analysis, performed to evaluate the practical performance of our approach, gave a 66{\%} accuracy rate in predicting toxic responses based on the pretreatment metabolite profiles. Hence, we provide a working model that can explain the idiopathic toxicity mechanism based on marker metabolites found by NMR analysis consistent with tissue NADH measurements. Thus, a pharmacometabonomic approach using pretreatment metabolite profiles may help expedite personalized chemotherapy of anticancer drugs.",
keywords = "anticancer, cisplatin, pharmacometabonomics, prediction, toxicity",
author = "Kwon, {Hyuk Nam} and Mina Kim and He Wen and Sunmi Kang and Yang, {Hye Ji} and Choi, {Myung Joo} and Lee, {Hee Seung} and DalWoong Choi and Park, {In Suh} and Suh, {Young Ju} and Hong, {Soon Sun} and Sunghyouk Park",
year = "2011",
month = "3",
day = "1",
doi = "10.1038/ki.2010.440",
language = "English",
volume = "79",
pages = "529--537",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach

AU - Kwon, Hyuk Nam

AU - Kim, Mina

AU - Wen, He

AU - Kang, Sunmi

AU - Yang, Hye Ji

AU - Choi, Myung Joo

AU - Lee, Hee Seung

AU - Choi, DalWoong

AU - Park, In Suh

AU - Suh, Young Ju

AU - Hong, Soon Sun

AU - Park, Sunghyouk

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Cisplatin has been one of the most widely used anticancer agents, but its nephrotoxicity remains a dose-limiting complication. Here, we evaluated the idiopathic nature and the predose prediction of cisplatin-induced nephrotoxicity using a nuclear magnetic resonance (NMR)-based pharmacometabonomic approach. Cisplatin produced serious toxic responses in some animals (toxic group), but had little effect in others (nontoxic group), as judged by hematological and histological results. The individual metabolic profiles, assessed by urine NMR spectra, showed large differences between the post-administration profiles of the two groups, indicating the relevance of the NMR approach. Importantly, multivariate analysis of the NMR data showed that the toxic and nontoxic groups can be differentiated based on the pretreatment metabolite profiles. Leave-one-out analysis, performed to evaluate the practical performance of our approach, gave a 66% accuracy rate in predicting toxic responses based on the pretreatment metabolite profiles. Hence, we provide a working model that can explain the idiopathic toxicity mechanism based on marker metabolites found by NMR analysis consistent with tissue NADH measurements. Thus, a pharmacometabonomic approach using pretreatment metabolite profiles may help expedite personalized chemotherapy of anticancer drugs.

AB - Cisplatin has been one of the most widely used anticancer agents, but its nephrotoxicity remains a dose-limiting complication. Here, we evaluated the idiopathic nature and the predose prediction of cisplatin-induced nephrotoxicity using a nuclear magnetic resonance (NMR)-based pharmacometabonomic approach. Cisplatin produced serious toxic responses in some animals (toxic group), but had little effect in others (nontoxic group), as judged by hematological and histological results. The individual metabolic profiles, assessed by urine NMR spectra, showed large differences between the post-administration profiles of the two groups, indicating the relevance of the NMR approach. Importantly, multivariate analysis of the NMR data showed that the toxic and nontoxic groups can be differentiated based on the pretreatment metabolite profiles. Leave-one-out analysis, performed to evaluate the practical performance of our approach, gave a 66% accuracy rate in predicting toxic responses based on the pretreatment metabolite profiles. Hence, we provide a working model that can explain the idiopathic toxicity mechanism based on marker metabolites found by NMR analysis consistent with tissue NADH measurements. Thus, a pharmacometabonomic approach using pretreatment metabolite profiles may help expedite personalized chemotherapy of anticancer drugs.

KW - anticancer

KW - cisplatin

KW - pharmacometabonomics

KW - prediction

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=79951678399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951678399&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.440

DO - 10.1038/ki.2010.440

M3 - Article

VL - 79

SP - 529

EP - 537

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -